TSC2 and cancer: Actually, the AMKP activation can attenuate the mTOR signaling and inhibit cancer cell proliferation by phosphorylating the upstream tumor suppressor TSC1 and TSC2 to induce cell cycle arrest through the p53/p21/p27 pathway (25).